Metastasis-directed Radiotherapy (MDRT) for Men With De-novo Oligometastatic Prostate Cancer Treated With Long-term ADT (METANOVA)

Details

The METANOVA Trial investigates treating oligometastatic prostate cancer with metastasis-directed radiotherapy (MDRT) in addition to standard systemic and prostate-directed therapy. MDRT, using targeted radiation on all metastatic sites, aims to extend the time until cancer returns and potentially improve patient survival. Related Content: ClinicalTrials.gov Identifier: NCT06150417 Metastasis-dire...